This study focused on evaluating the diagnostic performance of the lung point (LP)- a lung ultrasound (LUS) sign in detecting and semi-quantifying pneumothorax (PTX), using computed tomography (CT) as the reference standard. The study included 150 patients who underwent CT-guided transthoracic biopsy (TTB) for lung lesions. Two radiologists blinded to the participant’s prior information performed LUS post-biopsy. The results showed that PTX was present on CT in 49/150 (32.3%) cases. The LP was positive in 36/150 (24%) patients, with a substantial agreement between the two radiologists (Cohen κ statistics = 0.8). The sensitivity and specificity of the LP were 73.5% (95%CI 66.5% to 80.5) and 100% (95%CI 97.6% to 100%), respectively. Moreover, the positive and negative predictive values were 100% (95%CI 97.6% to 100%) and 67.3% (95%CI 59.8% to 78.4%), respectively. In the semi-quantification of PTX, the location of LP was described in 36/49 (73.5%) patients. The sensitivity and specificity of this sign were 87.5% (95%CI 82.2% to 92.8%) and 96.4% (95%CI 92.4% to 98.9%), respectively. The positive and negative predictive values were 87.5% (95%CI 82.2% to 92.8%) and 96.4% (95%CI 92.4% to 98.9%), respectively. In conclusion, LP is a susceptible and specific LUS sign for diagnosing and semi-quantifying PTX.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.